Patents
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
07/2013
07/03/2013CN101952259B Benzodiazepine compound and pharmaceutical composition
07/02/2013US8476279 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
06/2013
06/27/2013WO2013096560A1 Excipient-free aerosol formulation
06/26/2013CN103180312A Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine
06/26/2013CN103180295A 多环四环素化合物 Polycyclic tetracycline compounds
06/20/2013CA2857197A1 Novel glp-1 receptor modulators
06/13/2013US20130150350 Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication
06/12/2013CN101573333B Inhibitors of histone deacetylase
06/11/2013US8461153 Benzodiazepinone compounds useful in the treatment of skin conditions
06/11/2013US8460704 Extended release formulation of nevirapine
06/06/2013US20130144054 Novel production method for isoquinoline derivatives and salts thereof
06/04/2013US8455479 Heterocyclic compounds
05/2013
05/29/2013EP2597088A1 P2x4 receptor antagonist
05/29/2013CN103121976A Preparation method of N-monosubstituted homopiperazines
05/28/2013US8450306 Bradykinin B1-receptor antagonists
05/28/2013CA2508621C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
05/23/2013US20130131034 Derivatives of aminoindanes, their preparation and their application in therapeutics
05/21/2013US8445482 Thieno- and furo-pyrimidine modulators of the histamine H4 receptor
05/16/2013WO2013068785A1 Indanone and indandione derivatives and heterocyclic analogs
05/16/2013US20130123243 Diamine derivatives as inhibitors of leukotriene a4 hydrolase
05/14/2013US8440654 Thieno- and furo-pyrimidine modulators of the histamine H4 receptor
05/14/2013US8440653 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists
05/10/2013WO2013064231A1 SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3)
05/08/2013CN103086986A Preparation method and application of 1,4-benzodiazepine-N-nitrosamine intermediate
05/07/2013US8435981 2-(heterocyclylbenzyl)pyridazinone derivatives
05/02/2013WO2013033246A9 Novel benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof
05/02/2013US20130109019 Hapten conjugates for target detection
05/01/2013CN103080094A P2X4 receptor antagonist
04/2013
04/30/2013US8431567 Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligands
04/25/2013US20130102774 Thionation process and a thionating agent
04/24/2013CN1802159B 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
04/10/2013CN103030600A Synthesis process of hapten 3-(3-chlorine-propyl) diazepam
04/10/2013CN101941953B Nitrogenous heterocyclic substituted hydrazide compounds as well as preparation methods and applications thereof
04/10/2013CN101657432B Dihydro-benzo[B][1,4]diazepin-2-one sulfonamide derivatives
04/10/2013CN101657411B Preparation methods of 4-acetyl-2,3,4,5-tetrahydro- benzo[1,4]diazepine and their intermediates
04/09/2013US8415343 Autoimmune diseases; antiinflammatory agents; antiproliferative agents; benzodiazepine compound
04/09/2013US8415340 Triazine kinase inhibitors
03/2013
03/27/2013CN101233117B Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
03/19/2013US8399681 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators
03/19/2013US8399456 2,5-disubstituted arylsulfonamide CCR3 antagonists
03/19/2013US8399455 Compounds useful as chemokine receptor antagonists
03/12/2013US8394805 Compounds
03/07/2013WO2013033246A2 Novel benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof
03/07/2013CA2847247A1 Novel benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof
03/06/2013EP2565183A1 Glycine transporter-1 inhibitors
03/05/2013US8389720 Quinolone neuropeptide S receptor antagonists
02/2013
02/28/2013WO2013028382A1 Benzopiperazine derivatives as cetp inhibitors
02/27/2013EP2562168A1 Therapeutic piperazines as PDE4 inhibitors
02/19/2013US8377927 Compositions and methods for treatment of cancer
02/14/2013US20130040941 Benzodiazepine compound and pharmaceutical composition
02/07/2013US20130035329 Therapeutically active compositions and their methods of use
02/06/2013EP2552890A1 Polycyclic tetracycline compounds
02/06/2013CN102127023B 7-membered ring compound, process for producing the same, and use thereof
01/2013
01/29/2013US8362010 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
01/29/2013US8362009 Substituted diazepan orexin receptor antagonists
01/29/2013US8361779 Buffer compounds
01/29/2013CA2672860C Inhibitors of poly(adp-ribose)polymerase
01/23/2013CN101490017B Therapeutic piperazines as pde4 inhibitors
01/22/2013US8357679 Hexafluoroisopropanol derivatives
01/16/2013CN102884044A Derivatives of aminoindanes, their preparation and their application in therapeutics
01/16/2013CN102872022A Nicotinic receptor agonists for the treatment of inflammatory diseases
01/15/2013US8354402 Polyarylcarboxamides useful as lipid lowering agents
01/10/2013WO2013006485A1 Fused benzoxazepinones as ion channel modulators
01/10/2013US20130012492 Fused heterocyclic compounds as ion channel modulators
01/10/2013US20130012485 Organic compounds
01/10/2013CA2838223A1 Fused benzoxazepinones as ion channel modulators
01/09/2013EP2542524A1 Derivatives of aminoindanes, their preparation and their application in therapeutics
01/08/2013US8349824 Triazolopyridine compounds
01/03/2013US20130004518 Cyclic amine bace-1 inhibitors having a benzamide substituent
01/02/2013EP2539341A1 Derivatives of 1-phenyl-1,5-dihydro-benzo[b][1.4]diazepine-2.4-dione as inhibitors of hiv replication
01/02/2013CN101479243B Glycine transporter-1 inhibitors
01/01/2013US8343958 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5-receptor antagonists
01/01/2013US8343954 Compositions and methods for inhibition of the JAK pathway
12/2012
12/27/2012WO2012176878A1 Proteasome inhibitor
12/27/2012WO2012137152A3 Method for preparing formamide compounds
12/27/2012WO2011100838A9 Derivatives of l-plienyl-1.5-diliydio-benzo[b] [1.4]diazepine-2.4-dione as inhibitors of hiv replication
12/27/2012US20120328599 Inhibitors of receptor tyrosine kinases (rtk) and methods of use thereof
12/25/2012US8338614 e.g. 2-[5-(5-methyl-1,3-diphenyl-1H-pyrazol-4-yl)-1,3,4-oxadiazol-2-yl]-1-phenylpropan-2-amine; neurodegenerative diseases; preventing the formation of insoluble amyloid beta and arresting the production of amyloid beta
12/25/2012US8338406 Benzodiazepine compound and pharmaceutical composition
12/18/2012US8334283 Compositions and methods for treating, reducing, ameliorating, or preventing infections
12/18/2012CA2511214C Asthma and allergic inflammation modulators
12/12/2012CN102816090A Carbamate compounds, preparation method and application thereof
12/12/2012CN102120732B Preparation method of homopiperazine and derivative thereof
12/04/2012US8324202 5-phenyl-1H-benzo [E] [1,4] diazepine compounds substituted with an hydroxamic acid group as histone deacetylase inhibitors
12/04/2012US8324200 Compositions and methods for inhibition of the JAK pathway
11/2012
11/29/2012US20120302553 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
11/27/2012US8318726 Benzylidineanthracenone linked pyrrolobenzodiazepine hybrids useful as anticancer agents and process for the preparation thereof
11/27/2012US8318052 Diketopyrrolopyrrole cocrystals with high transparency
11/27/2012CA2515790C Heterocyclic kinase inhibitors
11/27/2012CA2449830C New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
11/20/2012US8314091 N-benzyl,N'-arylcarbonylpiperazine derivatives
11/15/2012US20120289498 Compositions And Methods Relating To Novel Compounds And Targets Thereof
11/08/2012US20120283249 Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
11/07/2012CN101687886B Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome
11/01/2012WO2012148553A1 Process for the preparation of an orexin receptor antagonist
10/2012
10/31/2012EP2518056A1 Seven-membered ring compound and pharmaceutical use therefor
10/31/2012CN102762541A Diazepam derivatives as modulators of chemokine receptors
10/30/2012US8299063 Amido-thiophene compounds and their use
10/30/2012US8299057 Substituted indazole derivatives active as kinase inhibitors
10/30/2012US8298512 Methods of determining β-III tubulin expression
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 60